Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00423371
Status:
COMPLETED
Last Update Posted:
2011-05-19
First Post:
2007-01-17
Brief Title:
Double-BlindRandomizedPlacebo-Controlled Efficacy Safety Study of EUFLEXXA for Treatment of OA of the First CMC
Sponsor:
Ferring Pharmaceuticals
Organization:
Ferring Pharmaceuticals
Study Overview
Official Title:
A Double-Blind Randomized Placebo-Controlled Study of the Efficacy and Safety of EUFLEXXA for Treatment of Osteoarthritis OA of the First Carpometacarpal CMC Joint
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This multicenter double-blind randomized parallel-group active-controlled trial will be performed in approximately 80 subjects with chronic idiopathic osteoarthritis OA of the first carpo-metacarpal joint CMC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None